Global Automated Liquid Handling Market is segmented By Procedure (Plate Reformatting, Plate Replication, PCR Setup, High Throughput screening, Whole Genome Amplification, Cell Culture, Others), By End User (Laboratories, Research Organizations, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029
The Global "Automated Liquid Handling Market" is expected to grow at a CAGR of 8% during the forecasting period (2022-2029).
- A liquid handling robot is used in automation of chemical or biochemical laboratories. It is a robot that dispenses a selected quantity of reagent, samples or other liquid to a designated container.
- Automated liquid handling systems reduce processing time, decrease sample contamination, and increase accuracy in bioassays.
- These systems release researchers from long, repetitive, laborious tasks, and free up time for other assays, lab reports, and other lab duties.
- Biology research labs and drug development labs are among the laboratories that have limited sample contamination and freed up personnel to do other tasks by using a multipurpose liquid handling automated workstation.
- The workstations can measure out samples, add reagents, and make sure liquids are added to bioassays in a uniform fashion.
- Increasing technological developments are primarily driving automated liquid handling system market in recent years and expected to increase over the forecast period.
- Technological developments are reducing errors, increasing accuracy, and saving time when compared to traditional procedures.
- For instance, in 2019, Andrew Alliance a leading company in the development and commercialization of robotics for the life sciences sector provided Andrew + a system that permits repeatable, traceable pipetting with connected single and multichannel electronic pipettes.
- The robot performs complex manipulations using a wide range of compatible accessories, along with flexible configurations of Andrew pipettes.
- Biological research and drug development are boosting the global automated liquid handling systems. According to The Pharmaceutical Research and Manufacturers of America in 2017, in United States, biopharmaceutical industry invested an estimated $90 billion in research and development (R&D) in 2016.
- These research and drug development activities require automated liquid handling systems for accurate and better results.
- However huge cost of devices is hampering the growth of global automated liquid handling system market over the forecast period.
- Based on the application global automated liquid handling system is categorized into clinical trials, science, and biological research.
- Clinical trials had the dominant share in 2018 and anticipated to increase further over the forecast period due to increasing number of drug discovery procedures.
- According to Healthcare Information and Management Systems Society in United States, in 2018, the expenditure on clinical research and drug discovery is expected to reach $65.2 billion by 2025.
- Science and biological research hold the second largest market share. These researches require accurate transport and delivery of fluids for enhanced results.
- For instance, Labcyte a leading manufacturer of automated liquid handling systems launched the most advanced Echo® 655T Liquid Handler which is designed to support a wide range of applications in drug discovery and fundamental research.
- The system provides exceptional precision and is capable of accurately transferring volumes as small as 2.5nL from 384- and 1536- well plates, as well as 96-tube racks.
- When fully automated workflows are required, the Echo® 655T system can be integrated with Labcyte’s configurable Access™ Dual Robot System to achieve optimal levels of throughput.
- Based on end-user, the global automated liquid handling system market is segmented into research organizations and laboratories.
- The global automated liquid handling systems market is categorized into North America, Europe, Asia Pacific, South America, and Middle East, and Africa.
- North America is dominating automated global liquid handling systems due to increased number of clinical trials. According to American Cancer Institute in 2018, over 1.7 million people in the United States are diagnosed with cancer for the first time, at the same time more than 10,000 clinical trials required thousands of new patients for potentially life-saving experimental cancer drugs.
- Europe accounted for the second-largest market in recent years due to increase in a number of research and development activities in disease diagnosing and drug discovery procedures.
- For instance, in 2017, Medicxi, an investor in life science research funded Novartis AG with 300 million $ to develop novel technology and therapies in diseases such as cancer and diabetes.
- Asia Pacific is registering fastest CAGR over the forecast period due to increase in number of manufactures and suppliers in countries such as Japan, India, and China.
- The key players in global automated liquid handling systems are focusing on innovative products to increase their market presence.
- The major players in automated liquid handling market are Aurora Biomed Inc., Hamilton Company, PerkinElmer Inc., Agilent Technologies, Thermo Fisher Inc, Danaher Corporation, Tecan Group Limited, Eppendorf AG, Qiagen N.V, Corning Inc, Bio-Rad Laboratories.
- On January 29, 2019, FORMULATRIX, a provider of leading solutions for protein crystallization automation successfully developed the next generation of liquid handlers based on a unique microfluidic, positive-displacement technology. The MANTIS® and TEMPEST® are expected to revolutionize the reagent dispensing needs across genomics, proteomics, and cancer research fields.
- On April 10, 2018, Gilson demonstrated first cloud-connected liquid handling tools at Analytica 2018.
- On February 02, 2018, Tecan Launched Fluent® Gx Automation Workstation for use in regulated laboratories.
High Heat Foam Market
High Temperature Sealant Market
Single Cell Multiomics Market